A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to assess the safety and tolerability of human allogeneic mesenchymal bone marrow cells (aMBMC) administered intravenously to subjects with ST Segment Elevation Myocardial Infarction (STEMI).
Epistemonikos ID: 9202e71e5b3899289e8ea9e648a7378a6b3fad75
First added on: May 11, 2024